Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers Feb 22, 2024
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers Feb 20, 2024
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments Nov 9, 2023
Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting Nov 1, 2023
Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent Developments Aug 10, 2023
Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore Jul 11, 2023
